secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001437749-22-026924
Event type: litigation
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology settles defamation lawsuit for $16M; payments due in 2023 and 2024
--------------------------------------------------------------------------------

- Settlement with Dr. Fredric Eshelman for $16M resolves defamation lawsuit; no admission of liability.
- First payment of $8M due by Jan 31, 2023; second payment of $8M due by Nov 1, 2024.
- Original jury award of $22.4M vacated on appeal; settlement avoids new trial on damages.
- Lawsuit dismissed with prejudice; each party bears its own costs and fees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922026924/0001437749-22-026924-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922026924/pbyi20221109_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-026924

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer